261 – 280 of 327
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Multi-institutional Study of Symptomatic Deep Venous Thrombosis and Pulmonary Embolism in Prostate Cancer Patients Undergoing Laparoscopic or Robot-Assisted Laparoscopic Radical Prostatectomy
(
- Contribution to journal › Article
-
Mark
FGF-8 is involved in bone metastasis of prostate cancer
(
- Contribution to journal › Article
-
Mark
ETHICS AND PUBLIC HEALTH INTERVENTIONS.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
PSA-based screening for prostate cancer: How does it compare with other cancer screening tests?
(
- Contribution to journal › Scientific review
-
Mark
Serum Markers for Prostate Cancer : A Rational Approach to the Literature
(
- Contribution to journal › Scientific review
-
Mark
Screening for prostate cancer : an update.
(
- Contribution to journal › Scientific review
- 2007
-
Mark
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer
(
- Contribution to journal › Article
-
Mark
What should a urologist know about hereditary predisposition to prostate cancer?
(
- Contribution to journal › Scientific review
-
Mark
The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: Towards a biologically-based screening strategy
(
- Contribution to journal › Article
-
Mark
Interstitial photodynamic therapy for primary prostate cancer incorporating realtime treatment dosimetry
2007) Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVI 6427. p.4270-4270(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer - Results from a prospective, population-based randomized controlled trial
(
- Contribution to journal › Article
-
Mark
The continuing role of PSA in the detection and management of prostate cancer
(
- Contribution to journal › Article
-
Mark
Assessments of PSA Forms and hK2 as Very Early Predictors of Prostate Cancer
2007)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005 - Data from the national prostate cancer register in Sweden
(
- Contribution to journal › Article
-
Mark
NMR STUDIES ON STRUCTURE AND DYNAMICS OF TWO-DOMAIN PROTEINS
2007)(
- Thesis › Doctoral thesis (compilation)
-
Mark
PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section
(
- Contribution to journal › Article
-
Mark
Role of fibroblast growth factor 8 in growth and progression of hormonal cancer
(
- Contribution to journal › Scientific review
- 2006
-
Mark
Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer
(
- Contribution to journal › Article
-
Mark
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
(
- Contribution to journal › Article
-
Mark
Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration
(
- Contribution to journal › Article